How many studies have been conducted on Granisetron?

BiohacksAI has indexed 299 PubMed studies on Granisetron, including 135 randomized controlled trials (RCTs). 75% of studies involve human subjects.

What are the main research areas for Granisetron?

The primary research domains for Granisetron are 🌤️ Mood & Depression, 🔬 Oncology, 😴 Sleep. This is based on analysis of 299 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Granisetron

A serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic for cancer chemotherapy patients.

299+ PubMed studies analyzed · 135 RCTs · Evidence Score: 61.7

Research Domains

Granisetron has been studied across 17 research domains including 🌤️ Mood & Depression, 🔬 Oncology, 😴 Sleep, 💊 Pain, 🫁 Liver & Detox. The primary research focus is 🌤️ Mood & Depression with 37% of studies addressing this area.

Loading evidence profile...

This evidence profile for Granisetron is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.